Upstream Processing

Algenuity develops green solution for pharma with algae platform

07-Aug-2018 By Ben Hargreaves

Algenuity has launched the MERIT project to develop renewable methods of producing therapeutic agents.

US FDA puts gene-therapy on hold after DNA fragment found in plasmids

27-Jul-2018 By Maggie Lynch

Sarepta’s gene therapy clinical trial is put on hold by the US FDA after DNA fragment was found in plasmids during quality assurance testing.

Catalent brings in Berkeley Lights to optimise cell lines

18-Jul-2018 By Ben Hargreaves

Catalent has agreed a deal to apply Berkeley Lights’ Beacon optofluidic platform to its cell lines.

NEWS IN BRIEF

Selexis and Symphogen expand partnership to progress two mAbs

11-Jul-2018 By Ben Hargreaves

Selexis and Symphogen have announced that the latter has submitted INDs for clinical programmes to progress two mAbs using Selexis’ platform.

Pluristem brings in Thermo Fisher to ‘transform cell therapy manufacturing’

11-Jul-2018 By Ben Hargreaves

Pluristem Therapeutics has announced that it has agreed a strategic collaboration with Thermo Fisher to improve the process by which cell therapies are manufactured.

Abzena signs $5.9m manufacture agreement with Telix

04-Jul-2018 By Ben Hargreaves

Abzena has revealed that it has signed a GMP manufacturing and bioconjugation deal with Telix worth $5.9m.

Entegris: Growing demand for single-use tech drives Flex Concepts buy

03-Jul-2018 By Flora Southey

Entegris says buying Flex Concepts will help secure its supply of disposable bioprocessing bags and fluid transfer technologies.

CellGenix expands cell culture reagent facility in Germany, plans filling/freeze-drying line

22-Jun-2018 By Flora Southey

CellGenix has added quality control and R&D laboratories as well as logistics and warehouse space to its headquarters in Freiburg, Germany.

GE looks to speed drug discovery with new high capacity system

19-Jun-2018 By Melissa Fassbender

GE has introduced a new high capacity system designed to improve productivity in the increasingly complex drug discovery process.

ADC Bio: Biotech may 'hold the key' to innovation adoption

08-Jun-2018 By Flora Southey

CDMOs need to respond to biotech innovation at an R&D level to improve efficiency in antibody-drug conjugate manufacturing, says ADC Bio.

GE grows FlexFactory presence in China with another cell therapy plant deal

08-Jun-2018 By Flora Southey

GE Healthcare has announced plans to install its second FlexFactory manufacturing platform for cell therapy, this time at Xiangxue Pharmaceutical’s site in Guangzhou, China.

GE boosts powdered cell culture media capacity in ‘mature’ markets

18-May-2018 By Flora Southey

GE Healthcare Life Sciences is expanding powdered cell culture media production in Austria and the US, where it says longer shelf-life and reduced transport costs are driving demand.

INTERPHEX 2018

Avid Bioservices: 'The single-use facility is not all sunshine'

18-May-2018 By Flora Southey

Fluid distribution and warehouse management challenges are among the ‘pitfalls’ of the single-use biopharmaceutical facility, says Avid Bioservices executive.

ADC Bio’s $1.5m investment to boost antibody-drug conjugate manufacturing

01-May-2018 By Flora Southey

ADC Bio has announced receipt of a £1.14m investment it says will help reduce antibody-drug conjugate manufacturing time and costs.

Sanofi using Berkeley Lights’ tech to catalyze cell line development

20-Apr-2018 By Melissa Fassbender

Berkeley Lights has signed a new agreement with Sanofi through which the company will use its Beacon OptoFluidic Platform to fast-track cell line development.